Very promising data from a trial with an anti-inflammatory drug called Baricitinib in Covid19- 38% decrease in mortality.https://t.co/KK4tkq3ir0 pic.twitter.com/cy4aEJmc7e
— Luke O'Neill (@laoneill111) September 1, 2021
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00331-3/fulltext
Share:
- Click to share on Facebook (Opens in new window)
- Click to share on LinkedIn (Opens in new window)
- Click to share on Twitter (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on Telegram (Opens in new window)
- Click to share on WhatsApp (Opens in new window)
- Click to email a link to a friend (Opens in new window)
